Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss.Published in:Biomarker Insights, 2014, n. 9, p. 1, doi. 10.4137/BMI.S13965By:Christy, Alap L.;D'Souza, Vivian;Babu, Ruby P.;Takodara, Sohil;Manjrekar, Poornima;Hegde, Anupama;Rukmini, M. S.Publication type:Article